2026-04-25T11:13:06Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:29311 2026-03-26T04:43:28Z

Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC - Efficacy and Safety (Meeting Abstract) /unibl/sci/idNaucniRad:13157 https://dx.doi.org/doi: 10.1093/annonc/mdu165.175 Conference Paper text 2014 S. Jungić, G. Kecman Malčić, I. Rakita, D. Jovanović, R. Gajanin, Z. Marić, Z. Gojković, B. Tubić, Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC - Efficacy and Safety (Meeting Abstract), Annals of Oncology, Vol. 25(2), pp. 68 - 68, 2014 http://annonc.oxfordjournals.org/content/25/suppl_2/ii68.3.full 68 68 This article appears in:ESMO 16th World Congress on Gastrointestinal Cancer, 25–28 June 2014, Barcelona, Spain Annals of Oncology, Vol. 25(2) /unibl/author/Saša Jungić /unibl/author/Gordana Kecman Malčić /unibl/author/Ivanka Rakita /unibl/author/Dušan Jovanović /unibl/author/Radoslav Gajanin /unibl/author/Zdravko Marić /unibl/author/Zdenka Gojković https://www.unibl.org/sr-lat/fis/zaposlen/3255-biljana-tubic This article appears in:ESMO 16th World Congress on Gastrointestinal Cancer, 25–28 June 2014, Barcelona, Spain Annals of Oncology, Vol. 25(2) 68 68 /unibl/author/Saša Jungić /unibl/author/Gordana Kecman Malčić /unibl/author/Ivanka Rakita /unibl/author/Dušan Jovanović /unibl/author/Radoslav Gajanin /unibl/author/Zdravko Marić /unibl/author/Zdenka Gojković https://www.unibl.org/sr-lat/fis/zaposlen/3255-biljana-tubic https://www.pub.unibl.org/s/cir/item/29311